RU94045256A - Применение бензо[g]хинолинов - Google Patents

Применение бензо[g]хинолинов

Info

Publication number
RU94045256A
RU94045256A RU94045256/14A RU94045256A RU94045256A RU 94045256 A RU94045256 A RU 94045256A RU 94045256/14 A RU94045256/14 A RU 94045256/14A RU 94045256 A RU94045256 A RU 94045256A RU 94045256 A RU94045256 A RU 94045256A
Authority
RU
Russia
Prior art keywords
quinolines
benzo
prevention
compounds
glaucoma
Prior art date
Application number
RU94045256/14A
Other languages
English (en)
Inventor
Рудольф Маркштайн
De]
Original Assignee
Сандоз Лтд. (CH)
Сандоз Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сандоз Лтд. (CH), Сандоз Лтд. filed Critical Сандоз Лтд. (CH)
Publication of RU94045256A publication Critical patent/RU94045256A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Соединения формулы, приведенной в описании, применимы для лечения состояний, при которых желательно предотвращение или снижение прогрессирующей атрофии зрительного нерва, в частности, глаукомы.

Claims (1)

  1. Соединения формулы, приведенной в описании, применимы для лечения состояний, при которых желательно предотвращение или снижение прогрессирующей атрофии зрительного нерва, в частности, глаукомы.
RU94045256/14A 1993-12-21 1994-12-20 Применение бензо[g]хинолинов RU94045256A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939326010A GB9326010D0 (en) 1993-12-21 1993-12-21 Improvements in or relating to organic compounds
GB9326010.7 1993-12-21

Publications (1)

Publication Number Publication Date
RU94045256A true RU94045256A (ru) 1996-10-20

Family

ID=10746904

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94045256/14A RU94045256A (ru) 1993-12-21 1994-12-20 Применение бензо[g]хинолинов

Country Status (15)

Country Link
EP (1) EP0659430A1 (ru)
JP (1) JPH07215872A (ru)
KR (1) KR950016753A (ru)
CN (1) CN1109332A (ru)
AU (1) AU689510B2 (ru)
CA (1) CA2138421A1 (ru)
CZ (1) CZ324094A3 (ru)
GB (1) GB9326010D0 (ru)
HU (1) HUT71497A (ru)
IL (1) IL112021A0 (ru)
NO (1) NO944906L (ru)
PL (1) PL306367A1 (ru)
RU (1) RU94045256A (ru)
SK (1) SK155994A3 (ru)
ZA (1) ZA9410210B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997038691A1 (fr) * 1996-04-17 1997-10-23 Sumitomo Pharmaceuticals Co., Ltd. Medicament pour neuropathie retinienne
TW378209B (en) * 1996-07-08 2000-01-01 Novartis Ag Benzo[g]quinoline derivatives, their preparation and the pharmaceutical composition containing them
US5922746A (en) * 1997-03-27 1999-07-13 Allergan Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma
SE0001438D0 (sv) 2000-04-18 2000-04-18 Axon Chemicals Bv New chemical compounds and their use in therapy
AU3932902A (en) 2000-11-22 2002-06-03 Allergan Sales Inc A high-throughput screen for identifying channel blockers that selectively distinguish transient from persistent sodium channels
PE20030240A1 (es) * 2001-07-09 2003-04-16 Novartis Ag DERIVADOS DE BENZO [g] QUINOLINA
US6479458B1 (en) 2001-11-08 2002-11-12 Allergan, Inc. Targeting the reverse mode of the Na+/Ca2+ exchanger for the treatment of optic neuropathy associated with glaucoma and ischemic optic neuropathy
US7361478B2 (en) 2001-11-20 2008-04-22 Allergan, Inc. High-throughput screen for identifying selective persistent sodium channels channel blockers
EG24415A (en) * 2002-03-07 2009-05-25 Novartis Ag Quinoline derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405626A (en) * 1980-10-03 1983-09-20 Pfizer Inc. 9-Hydroxyoctahydrobenzo(c)quinolines analgesic compositions containing them and processes for producing analgesic with them
EP0077754B1 (en) * 1981-10-16 1990-09-26 Sandoz Ag Novel pharmaceutically active 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinoline derivatives
FI873428A (fi) * 1986-08-18 1988-02-19 Houston Biotechnology Oftalmologiska kompositioner foer behandling av nervdegenerationer.
DE4114325A1 (de) * 1991-05-02 1992-11-05 Sandoz Ag Octahydrobenzo(g)chinolin, seine herstellung und verwendung
US5262422A (en) * 1991-05-02 1993-11-16 Sandoz Ltd. Octahydrobenzo[g]quinoline

Also Published As

Publication number Publication date
JPH07215872A (ja) 1995-08-15
KR950016753A (ko) 1995-07-20
AU8152294A (en) 1995-06-29
CZ324094A3 (en) 1995-09-13
AU689510B2 (en) 1998-04-02
SK155994A3 (en) 1995-07-11
CA2138421A1 (en) 1995-06-22
EP0659430A1 (en) 1995-06-28
NO944906D0 (no) 1994-12-19
CN1109332A (zh) 1995-10-04
IL112021A0 (en) 1995-03-15
ZA9410210B (en) 1996-06-21
GB9326010D0 (en) 1994-02-23
HU9403653D0 (en) 1995-02-28
PL306367A1 (en) 1995-06-26
HUT71497A (en) 1995-11-28
NO944906L (no) 1995-06-22

Similar Documents

Publication Publication Date Title
NO960380L (no) Middel til behandling av neurosykdommer
DE69831506D1 (en) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
CA2102241A1 (en) Use of macrolide compounds for eye diseases
HU9600834D0 (en) Quinazoline derivatives
ATE238792T1 (de) Verwendung von makroliden zur behandlung von glaukom
WO2001058891A3 (en) Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
CA2342211A1 (en) Antibiotic compositions for treatment of the eye, ear and nose
AU697679B2 (en) Treatment of tinnitis using neuroprotective agents
WO1997030677A3 (en) Pentafluorobenzenesulfonamides and analogs
ES2106573T3 (es) Composicion oftalmica que contiene un derivado de 1,5-benzoxatiepina para tratar glaucoma.
AU6143794A (en) Use of riluzole for treating aids-related neural disorders
EP0807633A3 (en) Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
NZ236034A (en) Pharmaceutical compositions containing imidazole derivatives; topical compositions for treating glaucoma
AU667593B2 (en) Inhibitors of HIV protease useful for the treatment of AIDS
RU94045256A (ru) Применение бензо[g]хинолинов
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
CZ63295A3 (en) 1 alpha-fluoro-25-hydroxy-16-en-23-in-cholecalciferol as such and for the use as a therapeutic active compound, its use for the preparation of a pharmaceutical preparation, process of its preparation and a pharmaceutical preparation based thereon
ATE180669T1 (de) Verwendung von pregnanderivaten zur behandlung von tumoren
AU2008995A (en) Improvements in or relating to organic compounds
GR3022604T3 (en) Inhibitors of hiv protease useful for the treatment of aids.
CA2348890A1 (en) Use of staurosporine derivatives for treating ocular neovascular diseases
WO2001002358A3 (en) Cyclized amide derivatives for treating or preventing neuronal damage
ATE153340T1 (de) Cyathane derivate und diese enthaltende nervenwachstumsfaktor produktion stimulatoren und antimikrobielle mittel
MXPA03012039A (es) Derivados de benzo [g]quinolina para tratar glaucoma y miopia.